Health Insurance Innovations, Inc. (NASDAQ:HIIQ) Given Buy Rating at Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their buy rating on shares of Health Insurance Innovations, Inc. (NASDAQ:HIIQ) in a report published on Wednesday, November 1st. They currently have a $38.00 price objective on the financial services provider’s stock.

“3Q17 results were solid. HIIQ reported strong 3Q17 results with revenue and EPS above FactSet consensus expectations and our estimates. Revenue of $63.3 million (+37.4% y/y) was above FactSet consensus of $58.3 million and our estimate of $62.8 million. Revenue growth was primarily driven by an increase in policies in force. In the quarter, HIIQ has seen a sales mix shift to more Health Benefits Plans. Adjusted EBITDA of 20.3% expanded 270bps, reflecting inherent leverage in the model. Adjusted EPS was $0.46 vs. FactSet consensus of $0.39 and our estimate of $0.45.”,” Cantor Fitzgerald’s analyst wrote.

A number of other equities analysts have also commented on HIIQ. Zacks Investment Research raised shares of Health Insurance Innovations from a hold rating to a buy rating and set a $33.00 price target on the stock in a report on Friday, August 4th. Canaccord Genuity reaffirmed a buy rating and set a $39.00 target price (up previously from $30.00) on shares of Health Insurance Innovations in a report on Friday, August 4th. Craig Hallum reaffirmed a buy rating and set a $38.00 target price (up previously from $28.00) on shares of Health Insurance Innovations in a report on Thursday, August 3rd. ValuEngine raised shares of Health Insurance Innovations from a hold rating to a buy rating in a research report on Friday, September 1st. Finally, Northland Securities reissued a buy rating and set a $37.00 price target on shares of Health Insurance Innovations in a research report on Tuesday, October 17th. One equities research analyst has rated the stock with a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company’s stock. The company presently has an average rating of Buy and a consensus target price of $30.86.

Health Insurance Innovations (NASDAQ:HIIQ) traded up $0.15 on Wednesday, reaching $24.05. 374,792 shares of the company’s stock were exchanged, compared to its average volume of 638,725. The stock has a market capitalization of $395.37, a PE ratio of 16.26 and a beta of 0.63. Health Insurance Innovations has a 52-week low of $9.75 and a 52-week high of $37.38.

Health Insurance Innovations (NASDAQ:HIIQ) last announced its quarterly earnings results on Wednesday, November 1st. The financial services provider reported $0.46 EPS for the quarter, beating the Zacks’ consensus estimate of $0.35 by $0.11. The company had revenue of $63.34 million for the quarter, compared to analysts’ expectations of $59.30 million. Health Insurance Innovations had a net margin of 5.98% and a return on equity of 21.32%. Health Insurance Innovations’s revenue was up 37.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.33 EPS. equities research analysts predict that Health Insurance Innovations will post 1.39 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece was originally published by BBNS and is the property of of BBNS. If you are viewing this piece on another publication, it was illegally copied and republished in violation of international copyright law. The legal version of this piece can be viewed at https://baseballnewssource.com/markets/health-insurance-innovations-inc-hiiq-receives-buy-rating-from-cantor-fitzgerald/1747899.html.

Health Insurance Innovations announced that its Board of Directors has approved a share repurchase program on Monday, October 16th that authorizes the company to repurchase $50.00 million in shares. This repurchase authorization authorizes the financial services provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.

In other news, CEO of HealthPocket Bruce Telkamp sold 9,970 shares of the business’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $36.19, for a total value of $360,814.30. Following the transaction, the insider now owns 19,500 shares of the company’s stock, valued at $705,705. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Sheldon Wang sold 4,530 shares of the business’s stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $32.73, for a total transaction of $148,266.90. Following the completion of the transaction, the insider now directly owns 224,894 shares in the company, valued at approximately $7,360,780.62. The disclosure for this sale can be found here. Insiders sold 48,576 shares of company stock valued at $1,584,152 over the last quarter. Company insiders own 30.00% of the company’s stock.

A number of hedge funds have recently bought and sold shares of HIIQ. PNC Financial Services Group Inc. bought a new position in Health Insurance Innovations during the second quarter valued at $113,000. Advisors Asset Management Inc. bought a new position in Health Insurance Innovations during the third quarter valued at $142,000. Nationwide Fund Advisors purchased a new stake in shares of Health Insurance Innovations during the second quarter valued at $149,000. Chicago Equity Partners LLC purchased a new stake in shares of Health Insurance Innovations during the third quarter valued at $158,000. Finally, First Trust Advisors LP purchased a new stake in shares of Health Insurance Innovations during the third quarter valued at $171,000. Institutional investors and hedge funds own 63.72% of the company’s stock.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Analyst Recommendations for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees
Free Agency Season Has Finally Heated Up
Free Agency Season Has Finally Heated Up


Leave a Reply

 
© 2006-2017 BBNS.